CLINICAL_TRIALS
trial_result
· 2021-08-04
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis [Phase 2]
Summary
Phase 2 study evaluating the efficacy and safety of PF-06700841 in active psoriatic arthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-08-04